Mobile Menu

Search Results

Search results for: Technology

Biologically-validated AI is how scientists are realising the full potential of single-cell RNA sequencing

The promise of single-cell gene expression data Genomic data are an excellent source of novel disease biomarkers and targets. In […]

Simple and powerful target enrichment method seeks cool new applications. Apply now.

*** This post was written by Dr. Anja Brunner, science writer (Science Inbound) Interview with Cristina Gamba, Global Product Manager […]

Pharma stakeholders to progress data-driven development at D4 Global

Front Line Genomics is delighted to announce the launch of D4 Global: the world’s first truly global event focusing on […]

Capture the dark genome: From repeat-expansions to CRISPR unintended mutations – Webinar Summary

Tackling Disease-Related Repeat Expansion Analysis – Marzia Rossato What is the Dark Genome? The dark genome refers to parts of […]

Genetic risk for Alzheimer’s progression differs with sex

It is well documented that the genetic risk for Alzheimer’s has a sex bias. Sex bias in Alzheimer’s Carrying a […]

The Genetics Podcast: Analysing data in the cloud

In the latest episode of The Genetics Podcast, Patrick Short, CEO of Sano Genetics, interviews Dr Maria Chatzou Dunford, CEO […]

First Point-of-Care Test for COVID-19 using CRISPR announced

Binx Health and Sherlock Biosciences have announced a partnership to develop the world’s first point-of-care diagnostic test for COVID-19 using […]

Genetics Unzipped podcast: The eyes have it – saving sight, from genetics to gene therapy

In this episode of the Genetics Unzipped podcast, supported by the UK Medical Research Council, Kat Arney and stay-at-home roving […]

Webinar: Capture the dark genome – From repeat-expansions to CRISPR unintended mutations

Sequenced genomes retain a surprisingly large number of “dark” regions – sections that have proven difficult to characterise via short-read […]

Base editing outcomes predicted by machine learning model

Single nucleotide variants (SNVs) are implicated in about half of all genetic diseases and so, accurately targeting and editing these […]